Interestingly, in a recent study, CSF synaptotagmin-1 levels were higher in Alzheimer’s disease patients compared to those with frontotemporal dementia, and there was a tendency to increased levels in patients with likely tau pathology [306]. Here, MAPT is linked to Alzheimer disease.